Jeffrey Glushakow

Jeffrey Glushakow is a seasoned professional in corporate development and investment, currently serving as the Director of Corporate Development & Investment at WuXi Biologics since July 2022, where responsibilities include M&A, corporate venture investing, licensing, and strategic partnerships. Prior to this role, Glushakow held the position of Investment Banking Director at WG Partners LLP, specializing in M&A and capital raising services for life sciences clients. Experience also includes working as an Assistant Director at BDO UK LLP, focusing on corporate finance in life sciences, and as a Health Transactions & Restructuring Manager at Deloitte. Earlier in the career, Glushakow managed strategy and corporate development initiatives for Medibank Health Solutions, successfully entering Asia Pacific markets. Academic credentials include a Master’s Degree in International Business and Commerce from The University of Sydney Business School and a Bachelor’s Degree in Psychology from Syracuse University.